Central blood pressure (cBP), particularly central pulse pressure (PP), has a superior predictive ability of cardiovascular events and mortalities to brachial BP. [1] [2] [3] As invasive assessment of cBP is not feasible, a variety of methods of noninvasive cBP estimation have been developed. A radial tonometric method is predominantly used in studies; 4 however, the use of tonometric devices in-office or at-home in daily clinical practice is difficult as this method requires a trained operator to estimate cBP. In addition, a substantial brachial-to-radial systolic BP (SBP) amplification impairs the accuracy of this method. 5 Recently developed cuff-based oscillometric devices can yield cBP in an automatic and operator-independent manner. We previously reported that central pulsatile indices were associated with coronary atherosclerosis in elderly patients using a validated brachial cuff-based device, Mobil-O-Graph (IEM, Stolberg, Germany). 6, 7 To generate an aortic pulse wave from the brachial waveform, this device is able to apply 2 calibration methods: brachial SBP/diastolic BP (DBP) or brachial mean arterial pressure (MAP)/DBP. It has been demonstrated that central SBP calibrated with brachial MAP/DBP (cSBPmd) is more accurate, 6 more strongly associated with cardiac structural abnormalities 8, 9 and more predictive for mortality in chronic kidney disease patients 10 than central SBP values calibrated with brachial SBP/DBP (cSBPsd). Thus, the MAP/DBP calibration is likely to be more suitable to derive cSBP for better estimation of risk related to BP and refined hypertension management decisions than the SBP/DBP calibration. With regard to central pulsatile indices (namely PP and PP-derived indices), the effect of calibration methods on the diagnostic ability of these indices has not been reported until now, although central pulsatile indices were reported to be more predictive for cardiovascular events 1,11 or mortality 3 than cSBP. In our previous study, we used only MAP/DBP calibration to measure cBP and did not assessed the discriminatory ability using SBP/DBP calibration. 7 The aim of the present study was to assess the diagnostic ability of central pulsatile indices
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BACKGROUND
Several studies have reported that central systolic blood pressure (SBP) estimation is affected by calibration methods. However, whether central pulsatile indices, namely pulse pressure (PP) and fractional PP (FPP) (defined as PP/mean arterial pressure (MAP)), also depend on calibration methods remains uninvestigated. This study assessed the accuracy and discriminatory ability of these indices for coronary atherosclerosis using 2 calibration methods.
METHODS
Post-hoc analysis of a previous cross-sectional study (n = 139) that investigated the association between central pulsatile indices and coronary atherosclerosis. A validated-oscillometric device provided PP and FPP at the brachial artery (bPP and bFPP) and central artery using 2 calibration methods: brachial SBP/diastolic BP (DBP) (cPPsd and cFPPsd) and MAP/DBP (cPPmd and cFPPmd). Accuracy was assessed against invasive measurements (cPPinv and cFPPinv). Multivariate logistic and linear regression analyses were performed to assess the association between pulsatile indices and the presence of coronary artery disease (CAD) and SYNTAX score, respectively.
for coronary artery disease (CAD) using the 2 calibration methods.
This is a post-hoc analysis of our previous study, which was a cross-sectional study investigating the association between noninvasive central pulsatile indices and coronary atherosclerosis. 7 
Patients
A total of 139 consecutive patients undergoing elective coronary angiography for the evaluation of stable CAD (n = 74) or follow-up of prior percutaneous coronary intervention (n = 65) at our institution were enrolled. Patients were divided into 2 age groups: group 1 (<70 years of age) and group 2 (≥70 years of age) as previously described. 7 Exclusion criteria were prior coronary surgical revascularization, hemodynamically significant valvular heart disease, left ventricular outflow tract obstruction, renal insufficiency on dialysis, and arrhythmias during evaluation. Our institutional Ethics Committee approved the study protocol, and written informed consent was obtained from each participant.
Hypertension was defined by brachial SBP ≥140 mm Hg and/or DBP ≥90 mm Hg, or the prescription of an antihypertensive drug. Diabetes mellitus was defined by a fasting blood glucose level ≥126 mg/dl or the use of a hypoglycemic agent or insulin.
BP measurement
PP was defined as the difference between SBP and DBP. Fractional PP (FPP) was defined as the ratio of PP to MAP. By correcting for the BP values, FPP serves as "standardized" PP in any range of BP values. As such, central FPP was confirmed as superior predictors to central PP for cardiovascular events. 11 Supine BPs were measured immediately prior to coronary angiography using a fluid-filled catheter at the ascending aorta and a validated cuff-based oscillometric manometer (Mobil-O-Graph) 6 concurrently. This device yields simultaneously measured values of brachial BP and cBP via an inbuilt ARC Solver algorithm (Austrian Institute of Technology, Vienna, Austria). To attain cBP, the brachial waveform was calibrated with brachial SBP/DBP (cBPsd) or MAP/DBP (cBPmd). A high-quality recording judged both by the device and the visual inspection was used for noninvasive estimation of brachial and cBP. Invasive measurements were performed for at least 10 seconds to derive the mean value of cBP (cBPinv).
Angiographic evaluation
Coronary angiography was performed according to the radial approach with standard techniques and was evaluated by at least 2 experienced cardiologists who were blinded to the hemodynamic data. CAD was defined as prior percutaneous coronary interventionor >50% stenosis in major epicardial coronary arteries upon visual evaluation. Severity of CAD was evaluated by the SYNTAX score (www.syntaxscore.com) for patients without prior percutaneous coronary intervention because it was validated in the native coronary artery. 12 
STATISTICAL ANALYSIS
All data were analyzed using STATA 13.0 software. Continuous values were expressed as mean ± SD. Normally continuous variables were assessed with Student's t-test, whereas continuous variables without a normal distribution were subjected to a Mann-Whitney U test. Logistic regression analysis was performed to assess the independent association between pulsatile indices and the presence of CAD. Odds ratios and 95% confidence intervals were calculated. The correlation between pulsatile indices and the SYNTAX score was evaluated by linear regression analysis. Multivariate analysis of logistic and linear regression was performed with a stepwise method including confounders with P values <0.15 in each analysis group. Variance inflation factor was assessed to identify multicollinearity among explanatory variables. All P values were 2-tailed. P <0.05 was considered statistically significant.
RESULTS
A total of 139 patients (mean age = 66.7 ± 12.2 years) were analyzed in 2 age groups: group 1 (<70 years of age) and group 2 (≥70 years of age). Group 1 (n = 72, mean age = 57.6 ± 9.6 years) included 58 men (80.5%), 51 CAD patients (70.8%), 48 hypertensive patients (66.7%), and 24 diabetic patients (33.3%). Group 2 (n = 67, mean age = 76.5 ± 5.1 years) included 48 men (71.6%), 44 CAD patients (65.7%), 53 hypertensive patients (79.1%), and 17 diabetic patients (25.4%).
In whole-group analysis, cSBPsd was largely underestimated and cSBPmd was slightly overestimated when compared with invasive measurement (cSBPsd: 127.9 ± 20.1; cSBPmd: 149.5 ± 25.6; cSBPinv: 145.6 ± 26.7 mm Hg). cDBPsd and cDBPmd were overestimated to the same degree (cDBPsd: 88.3 ± 12.6; cDBPmd: 89.2 ± 12.5; cDBPinv: 74.2 ± 13.6 mm Hg). Accordingly, cPPsd was largely underestimated and cPPmd was slightly underestimated when compared with invasive assessment (cPPsd: 39.6 ± 12.6; cPPmd: 60.3 ± 20.1; cPPinv: 71.4 ± 22.9). Similar results were obtained with regard to cFPP (cFPPsd: 0.35 ± 0.09; cFPPmd: 0.55 ± 0.14; cFPPinv: 0.70 ± 0.19). Both brachial SBP and PP were larger than cSBPsd and cPPsd; however, they were paradoxically smaller than cSBPmd and cPPmd (bSBP: 140.8 ± 22.6; bDBP: 87.0 ± 12.4; bPP: 53.8 ± 16.2 mm Hg).
In group 1, there was no significant difference in PP and FPP between non-CAD and CAD patients (data not shown). In group 2, only cFPPmd from among noninvasive indices was significantly elevated in CAD patients, as compared with non-CAD patients (bPP: 53.1 ± 14.4 vs. 58.4 ± 17.7 mm Hg, P > 0.05; cPPsd: 38.5 ± 10.6 vs. 41.6 ± 11.9 mm Hg, P > 0.05; cPPmd: 56.9 ± 16.3 vs. 65.9 ± 21.0 mm Hg, P > 0.05; bFPP: 0.49 ± 0.13 vs. 0.56 ± 0.14, P > 0.05; cFPPsd: 0.37 ± 0.08 vs. 0.42 ± 0.11, P > 0.05; and cFPPmd: 0.51 ± 0.13 vs. 0.60 ± 0.16, P = 0.02, respectively). A higher FPP value in CAD patients as by the MAP/DBP calibration method was compatible with that by the invasive method (cFPPinv: 0.70 ± 0.16 vs. 0.83 ± 0.18, P = 0.01).
We performed logistic regression analysis to determine the effect of calibration methods on the diagnostic ability of central pulsatile indices for CAD. In univariate and multivariate analyses, cFPPmd, but not cFPPsd, was associated with the presence of CAD in group 2 ( Table 1) . We confirmed that cFPPinv was also predictive for CAD in univariate (odds ratio (95% confidence intervals): 1.64 (1.13-2.38), P = 0.01) and multivariate (odds ratio (95% confidence intervals): 1.63 (1.07-2.47), P = 0.02) analyses in the same group. There was no significant association between pulsatile indices and CAD risk in group 1.
The correlation between the SYNTAX score and pulsatile indices in patients without prior percutaneous revascularization was examined (group 1, n = 38; group 2, n = 36). In univariate linear regression analysis, cPPmd, bFPP, and cFPPmd, but not cPPsd or cFPPsd, correlated with the SYNTAX score in group 2 (Supplementary Figure) . In multivariate analysis, cPPmd (standardized β = 0.39, P = 0.002), bFPP (standardized β = 0.42, P = 0.001), and cFPPmd (standardized β = 0.50, P < 0.001) independently correlated with the SYNTAX score in group 2. The standardized β regression coefficient of cFPPsd was 0.23 (P = 0.08), which was not significant and was the smallest among all the FPPs. There was no significant correlation between SYNTAX score and pulsatile indices in group 1.
DISCUSSION
To the best of our knowledge, this is the first study reporting the crucial effect of calibration methods on the accuracy and discriminatory ability of central pulsatile indices for coronary atherosclerosis. The findings demonstrated that brachial MAP/DBP calibration yielded more accurate and discriminatory central pulsatile indices than SBP/DBP calibration. The present data suggest that proper calibration methods should be selected to obtain noninvasive central pulsatile indices as clinically useful markers for risk stratification.
A recent meta-analysis of validation studies of several commercial devices indicated that calibration methods using brachial MAP/DBP provide a higher value and more accurate estimation of cSBP than brachial SBP/DBP. 13 This is likely to be applicable to cPP estimation because PP is the difference between SBP and DBP. With regard to central DBP, the difference in calibration methods has little or no effect on the accuracy of estimation, as brachial DBP is used for both calibration methods (SBP/DBP and MAP/DBP). In addition, DBP is relatively constant throughout the arterial tree. By contrast, as oscillometric methods consistently overestimate brachial DBP, central DBP is also overestimated regardless of calibration methods. Consequently, there is a systemic underestimation of cPP. 6, 14 In line with this, cPP was underestimated in both calibration methods during the present study, and cPPmd was closer to the invasive values than cPPsd. Notably, cPPmd was paradoxically larger than bPP. We hypothesize that this finding is due to the systemic underestimation of oscillometric bSBP that leads to the underestimation of oscillometric bPP. 15 Proper calibration methods should be determined not only by their measurement accuracy but also the diagnostic and prognostic ability of the derived cBP values. Using the Mobil-O-Graph, previous studies have revealed the superiority of cSBPmd to cSBPsd in the discriminatory ability for cardiac structural abnormalities 8, 9 and the prognostic ability for mortality; 10 however, few studies have assessed the impact of calibration modes on the clinical usefulness of central pulsatile indices. For the first time, the present study demonstrated the superior discriminatory ability of cPPmd and cFPPmd, as compared with cPPsd and cFPPsd, by assessing the association with coronary atherosclerosis using the same Mobil-O-Graph device. Moreover, when SBP/DBP was used for calibration, the discriminatory ability of cPP and cFPP were inferior to brachial indices, which was inconsistent with previous invasive studies. 2, 7 The consistent superiority in the present study supports the hypothesis that the brachial MAP/DBP calibration mode is a more promising approach that provides accurate and clinically useful cBP values. The prognostic ability of cPPmd and cFPPmd is also an important issue as several studies have suggested that the pulsatile component of cBP, namely cPP and cFPP, is more predictive for cardiovascular events 1, 11 or mortality 3 than the steady component of cBP (cSBP). The present data suggests b cFPPmd data were reproduced from Nakagomi et al. 7 Reprinted by permission of the publisher (Taylor & Francis Ltd, http://www.tandfonline.com).
the significance of calibration method selection when assessing the prognostic utility of central pulsatile indices.
LIMITATION
There were several limitations to the present study. First, the number of patients investigated was small. No significant association was detected between the pulsatile indices and coronary atherosclerosis in group 1, which may be due to the limited statistical power. However, the aim of this study, which was to compare the discriminatory ability of 2 calibration modes, was achieved in group 2. Second, the present study included high-risk patients undergoing coronary angiography. However, this is also a strength of the study as the early report included younger and relatively low-risk patients. 8 Finally, a single brachial cuff-based device was used, which has been validated against invasive measurement; 6 however, whether the major finding of this study is a device-specific issue should be investigated in the future.
In conclusion, the present analysis demonstrated that noninvasively assessed central pulsatile indices were calibration method dependent in not only accuracy, but also discriminatory ability. Central PP and FPP derived from the brachial MAP/DBP calibration method exhibited a greater association with coronary atherosclerosis, as compared with the brachial SBP/DBP calibration method. Issues regarding the calibration method are essential for the predictive ability of central pulsatile indices and should be considered in future studies.
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